Long-term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)-α antagonists versus TNF-α antagonists alone in psoriatic patients
Methotrexate, a folic acid analog, is the conventional systemic anti-psoriatic agent most commonly chosen for combination with biologics in the treatment of psoriasis. Real-world long-term safety data of this combination versus biologic treatment alone in dermatological practice are sparse.
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2021
|
| In: |
The journal of dermatology
Year: 2021, Jahrgang: 48, Heft: 6, Pages: 835-843 |
| ISSN: | 1346-8138 |
| DOI: | 10.1111/1346-8138.15754 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1111/1346-8138.15754 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.15754 
|
| Verfasserangaben: | Jochen H.O. Hoffmann, Christian Knoop, Kunt Schäkel, Alexander H. Enk, Eva N. Hadaschik |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1770301755 | ||
| 003 | DE-627 | ||
| 005 | 20220208214433.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210914s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/1346-8138.15754 |2 doi | |
| 035 | |a (DE-627)1770301755 | ||
| 035 | |a (DE-599)KXP1770301755 | ||
| 035 | |a (OCoLC)1295678927 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hoffmann, Jochen |e VerfasserIn |0 (DE-588)1074973267 |0 (DE-627)832794430 |0 (DE-576)443176698 |4 aut | |
| 245 | 1 | 0 | |a Long-term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)-α antagonists versus TNF-α antagonists alone in psoriatic patients |c Jochen H.O. Hoffmann, Christian Knoop, Kunt Schäkel, Alexander H. Enk, Eva N. Hadaschik |
| 246 | 3 | 3 | |a Long-term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)-alpha antagonists versus TNF-alpha antagonists alone in psoriatic patients |
| 264 | 1 | |c 2021 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a First published: 20 January 2021 | ||
| 500 | |a Gesehen am 14.09.2021 | ||
| 520 | |a Methotrexate, a folic acid analog, is the conventional systemic anti-psoriatic agent most commonly chosen for combination with biologics in the treatment of psoriasis. Real-world long-term safety data of this combination versus biologic treatment alone in dermatological practice are sparse. | ||
| 700 | 1 | |a Knoop, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schäkel, Knut |e VerfasserIn |0 (DE-588)1032757418 |0 (DE-627)739272896 |0 (DE-576)251064476 |4 aut | |
| 700 | 1 | |a Enk, Alexander |d 1963- |e VerfasserIn |0 (DE-588)1032757140 |0 (DE-627)739272535 |0 (DE-576)166173517 |4 aut | |
| 700 | 1 | |a Hadaschik, Eva |e VerfasserIn |0 (DE-588)1054876916 |0 (DE-627)792376684 |0 (DE-576)410969842 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The journal of dermatology |d Oxford [u.a.] : Wiley-Blackwell, 1974 |g 48(2021), 6, Seite 835-843 |h Online-Ressource |w (DE-627)507903730 |w (DE-600)2222121-9 |w (DE-576)253643619 |x 1346-8138 |7 nnas |a Long-term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)-α antagonists versus TNF-α antagonists alone in psoriatic patients |
| 773 | 1 | 8 | |g volume:48 |g year:2021 |g number:6 |g pages:835-843 |g extent:9 |a Long-term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)-α antagonists versus TNF-α antagonists alone in psoriatic patients |
| 856 | 4 | 0 | |u https://doi.org/10.1111/1346-8138.15754 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.15754 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210914 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 1054876916 |a Hadaschik, Eva |m 1054876916:Hadaschik, Eva |d 910000 |d 911300 |e 910000PH1054876916 |e 911300PH1054876916 |k 0/910000/ |k 1/910000/911300/ |p 5 |y j | ||
| 998 | |g 1032757140 |a Enk, Alexander |m 1032757140:Enk, Alexander |d 910000 |d 911300 |e 910000PE1032757140 |e 911300PE1032757140 |k 0/910000/ |k 1/910000/911300/ |p 4 | ||
| 998 | |g 1032757418 |a Schäkel, Knut |m 1032757418:Schäkel, Knut |d 910000 |d 911300 |e 910000PS1032757418 |e 911300PS1032757418 |k 0/910000/ |k 1/910000/911300/ |p 3 | ||
| 998 | |g 1074973267 |a Hoffmann, Jochen |m 1074973267:Hoffmann, Jochen |d 910000 |d 911300 |d 50000 |e 910000PH1074973267 |e 911300PH1074973267 |e 50000PH1074973267 |k 0/910000/ |k 1/910000/911300/ |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1770301755 |e 397780507X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedDisp":"2021","dateIssuedKey":"2021"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"title":[{"title":"The journal of dermatology","title_sort":"journal of dermatology","subtitle":"the official journal of the Japanese Dermatological Association"}],"part":{"year":"2021","pages":"835-843","extent":"9","volume":"48","text":"48(2021), 6, Seite 835-843","issue":"6"},"language":["eng"],"pubHistory":["1.1974 -"],"note":["Gesehen am 14.07.2021"],"recId":"507903730","disp":"Long-term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)-α antagonists versus TNF-α antagonists alone in psoriatic patientsThe journal of dermatology","type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"1974-","publisherPlace":"Oxford [u.a.] ; Tokyo ; Oxford [u.a.]","dateIssuedKey":"1974","publisher":"Wiley-Blackwell ; Japanese Dermatological Assoc. ; Blackwell"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1346-8138"],"eki":["507903730"],"doi":["10.1111/(ISSN)1346-8138"],"zdb":["2222121-9"]}}],"id":{"doi":["10.1111/1346-8138.15754"],"eki":["1770301755"]},"language":["eng"],"title":[{"title":"Long-term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)-α antagonists versus TNF-α antagonists alone in psoriatic patients","title_sort":"Long-term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)-α antagonists versus TNF-α antagonists alone in psoriatic patients"}],"recId":"1770301755","note":["First published: 20 January 2021","Gesehen am 14.09.2021"],"titleAlt":[{"title":"Long-term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)-alpha antagonists versus TNF-alpha antagonists alone in psoriatic patients"}],"physDesc":[{"extent":"9 S."}],"name":{"displayForm":["Jochen H.O. Hoffmann, Christian Knoop, Kunt Schäkel, Alexander H. Enk, Eva N. Hadaschik"]},"person":[{"display":"Hoffmann, Jochen","family":"Hoffmann","given":"Jochen","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Knoop, Christian","family":"Knoop","given":"Christian","role":"aut","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","family":"Schäkel","given":"Knut","display":"Schäkel, Knut"},{"roleDisplay":"VerfasserIn","role":"aut","family":"Enk","given":"Alexander","display":"Enk, Alexander"},{"family":"Hadaschik","given":"Eva","display":"Hadaschik, Eva","roleDisplay":"VerfasserIn","role":"aut"}]} | ||
| SRT | |a HOFFMANNJOLONGTERMSA2021 | ||